Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 6, Issue 252, Pages 252ra122-252ra122
Publisher
American Association for the Advancement of Science (AAAS)
Online
2014-09-04
DOI
10.1126/scitranslmed.3009332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Somatic Copy Number Alterations in Cancer Using Targeted Exome Capture Sequencing
- (2015) Robert J. Lonigro et al. NEOPLASIA
- Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma
- (2013) E. Angevin et al. CLINICAL CANCER RESEARCH
- Targeting Fibroblast Growth Factor Pathways in Prostate Cancer
- (2013) P. G. Corn et al. CLINICAL CANCER RESEARCH
- Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
- (2013) Dan R Robinson et al. NATURE GENETICS
- Targeting angiogenesis for the treatment of prostate cancer
- (2012) Emmanuel S Antonarakis et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
- (2012) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Regulation and Function of the FGF23/Klotho Endocrine Pathways
- (2012) Aline Martin et al. PHYSIOLOGICAL REVIEWS
- A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258), an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors, in Patients with Advanced Melanoma
- (2011) K. B. Kim et al. CLINICAL CANCER RESEARCH
- FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone
- (2011) Simon Wöhrle et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone
- (2011) Eleni Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- Phase II study of sunitinib in men with advanced prostate cancer
- (2009) M. Dror Michaelson et al. ANNALS OF ONCOLOGY
- Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
- (2009) N Murukesh et al. BRITISH JOURNAL OF CANCER
- A Fluorescence In situ Hybridization Screen for E26 Transformation-Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer
- (2008) B. Han et al. CANCER RESEARCH
- Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins
- (2008) Noriko Gotoh CANCER SCIENCE
- Fibroblast growth factor regulation of neovascularization
- (2008) Masahiro Murakami et al. CURRENT OPINION IN HEMATOLOGY
- Role of epithelial cell fibroblast growth factor receptor substrate 2 in prostate development, regeneration and tumorigenesis
- (2008) Y. Zhang et al. DEVELOPMENT
- FGF-8 is involved in bone metastasis of prostate cancer
- (2008) Maija P. Valta et al. INTERNATIONAL JOURNAL OF CANCER
- Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells
- (2008) Hewang Li et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started